500 TECHNOLOGY SQUARE, CAMBRIDGE, MA
Provides Second Quarter 2026 Financial and Corporate Update
Provides First Quarter 2026 Financial and Corporate Update
Annual Report to Security Holders
Investor Presentation
Strengthens Financial Leadership with Appointment of Ryan Maynard as Chief Financial Officer
Securities Purchase Agreement
Jeff Sacher Appointed Treasurer and Interim CFO at Foghorn Therapeutics
Q2
Q1
FY 2025
Q3
FY 2024
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Submission Upload
Correspondence
Post-Effective Amendment to Registration Statement